05:10:57 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-27 Bokslutskommuniké 2024
2024-11-19 Kvartalsrapport 2024-Q3
2024-08-30 Kvartalsrapport 2024-Q2
2024-05-28 Ordinarie utdelning ZZ B 3.00 SEK
2024-05-27 Årsstämma 2024
2024-05-22 Kvartalsrapport 2024-Q1
2024-02-27 Bokslutskommuniké 2023
2023-11-16 Kvartalsrapport 2023-Q3
2023-08-31 Kvartalsrapport 2023-Q2
2023-06-01 Ordinarie utdelning ZZ B 1.75 SEK
2023-05-31 Årsstämma 2023
2023-05-12 Kvartalsrapport 2023-Q1
2023-02-28 Bokslutskommuniké 2022
2022-11-17 Kvartalsrapport 2022-Q3
2022-08-26 Kvartalsrapport 2022-Q2
2022-06-01 Ordinarie utdelning ZZ B 2.00 SEK
2022-05-31 Årsstämma 2022
2022-05-13 Kvartalsrapport 2022-Q1
2022-02-28 Bokslutskommuniké 2021
2021-11-19 Kvartalsrapport 2021-Q3
2021-08-27 Kvartalsrapport 2021-Q2
2021-05-21 Ordinarie utdelning ZZ B 1.00 SEK
2021-05-21 Bonusutdelning ZZ B 0.25
2021-05-20 Årsstämma 2021
2021-05-18 Kvartalsrapport 2021-Q1
2021-02-26 Bokslutskommuniké 2020
2020-11-20 Kvartalsrapport 2020-Q3
2020-08-28 Kvartalsrapport 2020-Q2
2020-05-18 Ordinarie utdelning ZZ B 0.55 SEK
2020-05-18 Bonusutdelning ZZ B 0.15
2020-05-15 Årsstämma 2020
2020-05-14 Kvartalsrapport 2020-Q1
2020-02-28 Bokslutskommuniké 2019
2019-11-15 Kvartalsrapport 2019-Q3
2019-08-30 Kvartalsrapport 2019-Q2
2019-05-23 Bonusutdelning ZZ B 0.2
2019-05-23 Ordinarie utdelning ZZ B 0.50 SEK
2019-05-22 Årsstämma 2019
2019-05-16 Kvartalsrapport 2019-Q1
2019-02-28 Bokslutskommuniké 2018
2018-11-15 Kvartalsrapport 2018-Q3
2018-08-30 Kvartalsrapport 2018-Q2
2018-05-16 Ordinarie utdelning ZZ B 0.45 SEK
2018-05-15 Kvartalsrapport 2018-Q1
2018-05-15 Årsstämma 2018
2018-02-28 Bokslutskommuniké 2017
2017-11-13 Kvartalsrapport 2017-Q3
2017-08-31 Kvartalsrapport 2017-Q2
2017-05-26 Ordinarie utdelning ZZ B 0.25 SEK
2017-05-24 Årsstämma 2017
2017-05-10 Kvartalsrapport 2017-Q1
2017-02-28 Bokslutskommuniké 2016
2016-11-15 Kvartalsrapport 2016-Q3
2016-08-31 Kvartalsrapport 2016-Q2
2016-05-23 Ordinarie utdelning ZZ B 0.25 SEK
2016-05-20 Kvartalsrapport 2016-Q1
2016-05-20 Årsstämma 2016
2016-02-29 Bokslutskommuniké 2015
2015-11-23 Kvartalsrapport 2015-Q3
2015-08-31 Kvartalsrapport 2015-Q2
2015-05-22 Kvartalsrapport 2015-Q1
2015-05-06 Ordinarie utdelning ZZ B 0.25 SEK
2015-05-05 Årsstämma 2015
2015-02-27 Bokslutskommuniké 2014
2014-11-14 Kvartalsrapport 2014-Q3
2014-08-29 Kvartalsrapport 2014-Q2
2014-05-19 Ordinarie utdelning ZZ B 0.10 SEK
2014-05-16 Årsstämma 2014
2014-04-25 Kvartalsrapport 2014-Q1
2014-02-26 Bokslutskommuniké 2013
2013-10-25 Kvartalsrapport 2013-Q3
2013-08-31 Kvartalsrapport 2013-Q2
2013-06-13 Ordinarie utdelning ZZ B 0.00 SEK
2013-06-12 Årsstämma 2013
2013-04-25 Kvartalsrapport 2013-Q1
2013-02-28 Bokslutskommuniké 2012
2012-10-25 Kvartalsrapport 2012-Q3
2012-08-31 Kvartalsrapport 2012-Q2
2012-05-14 Kvartalsrapport 2012-Q1
2012-05-08 Årsstämma 2012
2012-02-28 Bokslutskommuniké 2011
2011-11-15 Kvartalsrapport 2011-Q3
2011-11-14 Extra Bolagsstämma 2011
2011-08-31 Kvartalsrapport 2011-Q2
2011-05-12 Kvartalsrapport 2011-Q1
2011-05-10 Ordinarie utdelning ZZ B 0.00 SEK
2011-05-09 Årsstämma 2011
2011-02-28 Bokslutskommuniké 2010

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHandel & varor
IndustriDetaljhandel
Zinzino är verksamma inom hälsovård och kosttillskott. Bolaget marknadsför och säljer produkter som berör en stor del områden som hudvård, immunsystem och viktnedsättning. Exempel på produkter som bolaget säljer inkluderar omega 3 olja, måltidsersättningar och kaffe. Zinzino innehar idag främst verksamhet inom Norden, Europa och Nordamerika. Huvudkontoret ligger i Västra Frölunda.
2019-11-22 14:00:00

Zinzino has signed a letter of intent with VMA Life in Singapore regarding the acquisition of this company for a quicker expansion within the Asian region.

Zinzino has the intention to sign a final acquisition agreement during the first quarter 2020 after completion of due diligence.

VMA Life is a direct sales company with the headquarters in Singapore that has business operations in Malaysia, Thailand, Taiwan, Hong Kong, China and Singapore. VMA Life sells health and beauty products.

"With Zinzino we will get a strong partner with great products which we believe will perfectly suit customers in our region", says Kenneth Koh, CEO and owner of VMA Life.

"Kenneth Koh and VMA Life will be a very important step for Zinzino towards the goal to expand in Asia. We had our sales start in Australia earlier this year and will have our sales start in India during 2020. By the acquisition of VMA Life we will get additional knowledge and competence in the Asian region. By introducing our products and our customer-focused sales concept we will create a leverage effect", says Dag Bergheim Pettersen, CEO Zinzino.

VMA Life is profitable, and the turnover is approx. 3 million USD. By this cooperation, with Zinzino's products and business model, Zinzino expects that VMA Life will increase sales already in 2020.

According to letter of intent, Zinzino shall, with entry, pay a fixed purchase price of 0.7 million USD paid partly in cash and partly in newly issued Zinzino shares. Then additional purchase prices will base on sales developments during 2020-2022. The total additional purchase price estimates at approximately 1 million USD. The acquisition will be financed with Zinzino's liquidity, and the additional purchase price will generate through profits from VMA Life.

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
Marcus Tollbom +46 (0) 70 190 03 12

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00,
email: certifiedadviser@penser.se

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 14:00 the 22nd of November 2019.

Zinzino AB (publ.) is a global Direct Sales company that markets and sells test-based nutrition, skincare and life-style products. Zinzino owns the Norwegian company BioActive Foods AS and the research and production unit Faun Pharma AS. Zinzino is based in Gothenburg, with additional offices in Helsinki, Riga, Oslo, Florida and Adelaide. Zinzino is a public company and its shares are listed on Nasdaq First North.